News
Nonacus partners with Birmingham University to develop bladder cancer test
Genetic testing company Nonacus has partnered with the University of Birmingham to develop a non-invasive, urine test for bladder cancer.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Genetic testing company Nonacus has partnered with the University of Birmingham to develop a non-invasive, urine test for bladder cancer.